Bioprospecting is a catch-all term for activities including discovery, acquisition, and utilization of novel biomaterials. This has historically been a controversial activity, often leading to unregulated commercialization of fauna (e.g., plants and medicinals) from third world countries for the benefit of commercial interests [Pros/Cons of Bioprospecting]. However, as a term in Molecular Biology, it reflects the growing need to discover new types of protein and nucleic acid parts, which can be used in biotechnology and basic research. The advent of multiple Next-Generation Sequencing technologies since 2006 now provides depth of information into the entire genomes (Metagenomics) of species previously inaccessible to basic research. 
Although not planned, one of the great examples of Bioprospecting is the story of Green Fluorescent Protein (GFP), a protein that has had a profound impact on every major field in modern biology. Originally isolated and characterized by Osamu Shimomura in the 1960's and 1970's from jellyfish and sea pansies, it was a mere oddity that conferred the eery bioluminescence of certain deep sea creatures. However, the subsequent cloning of the gene by Martin Chalfie and improvement into enhanced GFP by Roger Tsien made it into one of the modern workhorses in biology. This 40 year journey earned Shimomura, Chalfie, and Tsien the 2008 Nobel Prize in Chemistry. [History of GFP]
Metagenomics uses Next Generation Sequencing Technologies (e.g., Whole Genome Shotgun Sequencing (WGS), Roche 454, Illumina, ABI Solid) to completely sample the genomes of mixed microbial communities, generating an unbiased view of genomic sequence space. Estimates have suggested that greater than 99% of all microbes are unculturable in the lab and inaccessable to traditional laboratory analysis. Thus, these Next Generation Sequencing approaches allow for analysis of microbes that are small percentages of a microbial community. The current explosion in various Metagenomic projects (340 current projects, 1990 samples [GOLD database]) permits for entirely in silico approaches to identifying new gene families, with potential as parts in Synthetic Biology.
Craig Venter and his Yacht
In the early 2000's, the J. Craig Venter Institute set as one of its goals to sequence the genomic diversity in the oceans. Craig Venter used his personal yacht, the Sorcerer II, to traverse the Earth's oceans, taking samples of oceanic life and sequencing using Whole Genome Shotgun Sequencing. From this adventure, they uncovered 6 million proteins (double the current database), which consisted of 1,700 clusters of gene families with no known homology. The data also revealed homology for 6,000 unknown ORF families (ORFan). They found that a very high proportion of new genes belonged to viruses (likely marine phage), which current databases had underrepresented. 
Recent Successes of Bioprospecting using Metagenomics (Targeted Metagenomics)
A useful approach to Bioprospecting new genes involves sequence screening for specific families or functional screening in what is called Targeted Metagenomics. This approach has uncovered cold-adaptive rRNA's and sulfate reductases. Functional-screening using Metagenomics has led to more success in genereal, including identification of new antibiotic resistance genes and Cellulosic Biomass degrading genes .
New Antiobiotic Resistance
Cellulosic Biomass degrading genes found in Cow Rumen
Uses of New Parts
New genes found from Ruminant microbes are being used for generating fuel from biomass, proteins which have thus far been unknown to man. Genes identified in more extromophilic bacteria and archaea may be useful in metabolism of inorganic compounds. They may be useful in new genetic circuits in biotech applications. Finally, the genes will ultimately be useful as scaffolds for directed evolution studies, to generate new functions.
First, many of the current Next-Gen Sequencers are limited by their short-reads and need to perform emPCR, which can introduce bias. The coming introduction of single-molecule long read sequencers, such as that by Pacific Biosciences may alleviate some of these limitations. Finally, it is unlikely that genes found in nature will cover all the uses humanity may come up with. Since nature settles for genes that function "well-enough", this may be inadequate when humans are so concerned with efficiency and preoccupied with perfection.
- Chistoserdova L. . pmid:20495950.
- Yooseph S, Sutton G, Rusch DB, Halpern AL, Williamson SJ, Remington K, Eisen JA, Heidelberg KB, Manning G, Li W, Jaroszewski L, Cieplak P, Miller CS, Li H, Mashiyama ST, Joachimiak MP, van Belle C, Chandonia JM, Soergel DA, Zhai Y, Natarajan K, Lee S, Raphael BJ, Bafna V, Friedman R, Brenner SE, Godzik A, Eisenberg D, Dixon JE, Taylor SS, Strausberg RL, Frazier M, and Venter JC. . pmid:17355171.
- Suenaga H. . pmid:21366818.
- Brulc JM, Antonopoulos DA, Miller ME, Wilson MK, Yannarell AC, Dinsdale EA, Edwards RE, Frank ED, Emerson JB, Wacklin P, Coutinho PM, Henrissat B, Nelson KE, and White BA. . pmid:19181843.
- Hess M, Sczyrba A, Egan R, Kim TW, Chokhawala H, Schroth G, Luo S, Clark DS, Chen F, Zhang T, Mackie RI, Pennacchio LA, Tringe SG, Visel A, Woyke T, Wang Z, and Rubin EM. . pmid:21273488.